Concepedia

Brenton G. Mar

BG

Statistics

Publications

25

Citations

9.1K

H-Index

19

Active since

2001

Affiliations

Dana-Farber Cancer Institute(Current)

Brigham and Women's Hospital

Harvard University

University of Michigan

Stanford University

Brenton G. Mar is an author at Dana-Farber Cancer Institute specializing in medicine, molecular oncology, and oncology.

ORCID

Publications per year

2001–2023

25

Publications

25

Age-Related Clonal Hematopoiesis Associated with Adverse Outcomes

Siddhartha Jaiswal, Pierre Fontanillas, Jason Flannick et al. · New England Journal of Medicine · 2014 · 4.7K citations · Full text

, , +17

Acute myeloid leukemia ontogeny is defined by distinct somatic mutations

R. Coleman Lindsley, Brenton G. Mar, Emanuele Mazzola et al. · Blood · 2014 · 977 citations · Full text

, , +14

Prognostic Mutations in Myelodysplastic Syndrome after Stem-Cell Transplantation

R. Coleman Lindsley, Wael Saber, Brenton G. Mar et al. · New England Journal of Medicine · 2017 · 770 citations · Full text

, , +14

Clonal Hematopoiesis Associated With Adverse Outcomes After Autologous Stem-Cell Transplantation for Lymphoma

Christopher J. Gibson, R. Coleman Lindsley, Vatche Tchekmedyian et al. · Journal of Clinical Oncology · 2017 · 470 citations · Full text

, , +17

Somatic Mutations Predict Poor Outcome in Patients With Myelodysplastic Syndrome After Hematopoietic Stem-Cell Transplantation

Rafael Bejar, Kristen E. Stevenson, Bennett Adam Caughey et al. · Journal of Clinical Oncology · 2014 · 397 citations · Full text

, , +14

1–5 of 25